Terry Smith's top holdings (September 2025) include Meta Platforms Inc (META), a global technology conglomerate focusing on social media, virtual reality, and advertising.

Terry Smith is the founder and Chief Executive of Fundsmith LLP, an asset management firm based in London. His investment philosophy centers on identifying high-quality global businesses that can compound in value over the long term, often favoring companies with strong brands and consistent revenue streams.

Meta Platforms Inc (META)

Meta Platforms Inc. operates a suite of widely used social media and communication platforms, including Facebook, Instagram, and WhatsApp, alongside its ventures into virtual reality with Oculus. The company has a market capitalization of $1.86 trillion, and the current value of Terry Smith's position in Meta is $2.64 billion. Analysts have set a price target of $850.0 for the company, while discounted cash flow analysis suggests a value of $610.34 per share.
Here's an overview of Terry Smith's trades in Meta Platforms Inc:

Microsoft Corporation (MSFT)

Microsoft Corporation is a leading technology company providing a wide range of software products, services, and hardware. Its offerings include the Windows operating system, Microsoft Office suite, Azure cloud computing services, and Xbox gaming consoles. The company's market cap stands at $3.77 trillion, while this holding in Terry Smith's portfolio is currently worth $2.5 billion. A discounted cash flow analysis indicates a value of $387.56 per share, and analysts project a price target of $612.75.
Here's an overview of Terry Smith's trades in Microsoft Corporation:

Stryker Corp. (SYK)

Stryker Corp. is a prominent medical technology company known for its diverse product portfolio across orthopedics, medical and surgical equipment, and neurotechnology and spine. Its solutions are widely used in hospitals and healthcare facilities globally. Stryker has a market capitalization of $149.64 billion, with Terry Smith's position currently valued at $1.83 billion. Analysts have established a price target of $432.5 for the company, and its discounted cash flow value is $346.98 per share.
Here's an overview of Terry Smith's trades in Stryker Corp.:

Idexx Laboratories, Inc. (IDXX)

Idexx Laboratories, Inc. is a global leader in veterinary diagnostics, providing products and services for pets, livestock, and poultry. The company also offers water quality testing and dairy testing solutions. The company's market cap is $51.77 billion, and the current value of Terry Smith's holding in Idexx Laboratories is $1.71 billion. Analysts maintain a price target of $715.67 for IDXX, while its discounted cash flow analysis suggests a value of $165.67 per share.
Here's an overview of Terry Smith's trades in Idexx Laboratories, Inc.:

Philip Morris International Inc (PM)

Philip Morris International Inc. is a multinational tobacco company focused on the manufacture and sale of cigarettes, alongside a growing portfolio of reduced-risk products such as heated tobacco and e-vapor products. Its brands are distributed in markets around the world. With a market capitalization of $260.15 billion, the current value of Terry Smith's position in Philip Morris International is $1.52 billion. Analysts have set a price target of $181.0 for PM, and its discounted cash flow value stands at $235.88 per share.
Here's an overview of Terry Smith's trades in Philip Morris International Inc: